Vivacity-MG3 study comparing nipocalimab versus placebo treatment in patients with generalized myasthenia gravis: A Plain Language Summary of Publication

Future Neurology · Published 2026-04-24 · DOI 10.1080/14796708.2026.2647797

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1080/14796708.2026.2647797

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Gender and Functional Outcomes in Prestroke Depressive Patients Treated with Thrombolytic Therapy · Future Neurology · 2020 · Same journal
• Key results from a review of the abuse potential of lemborexant in patients with insomnia: a plain language summary · Future Neurology · 2025 · Same journal
• Hydrocephalus as a delayed presentation of Klebsiella pneumoniae ventriculitis: a case report · Future Neurology · 2022 · Same journal
• WASHC5 mutation extends the genotypic heterogeneity in early-onset Parkinson’s disease · Future Neurology · 2022 · Same journal
• Low-sodium oxybate improved symptoms in adults with idiopathic hypersomnia: A Plain Language Summary of Publication · Future Neurology · 2024 · Same journal
• The Trigeminocardiac Reflex: The Course of the Emerged Definition over the Last 21 Years · Future Neurology · 2020 · Same journal
• The Agitation in Alzheimer’s Screener for Caregivers (AASC ® ), a screening tool for agitation: a plain language summary · Future Neurology · 2026 · Same journal
• A rare case of Corynebacterium accolens isolated from brain abscess following mild nonpenetrating head trauma · Future Neurology · 2022 · Same journal
• Glioneuronal Tumors: Clinicopathological Findings and Treatment Options · Future Neurology · 2020 · Same journal
• NF-kB activation in intracranial aneurysm formation and early growth · Future Neurology · 2024 · Same journal